Trial Profile
A real world study comparing safety and efficacy of bivalirudin to unfractionated heparin (UFH) with or without glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Glycoprotein inhibitors; Heparin
- Indications Myocardial infarction
- Focus Adverse reactions; Therapeutic Use
- 24 Nov 2016 New trial record